← Leaderboards
James Robert Alfano
University Of Nebraska Lincoln
$2,295,589
Attributed
$2,295,589
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $430.3K · FY2006–12$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,295,589 · 4
By mechanism
R01$1,797,433 · 1
R56$360,106 · 1
P20$138,050 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Lincoln
Same institution · by research overlap
- Heriberto Cerutti$1,968,743
- Khalid Sayood$764,005
- Pill-Soon Song$179,742
- Dipti Ashok Dev$1,519,240
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsImmune ResponseMolecularPathogenAnimalsImmune SystemPlantsUnited States National Institutes Of HealthResourcesResearch PersonnelGlycineAdp RibosylationGrantMicrobeInterestCost EfficientIn VitroBiologicalAdp Ribose TransferasesCholera ToxinEukaryotaGenesChloroplastsBiochemical
Grant awards (8)
Suppression of innate immunity by an ADP-ribosyltransferase type III effector$355,544
R01 · FY2012 · AI · contact PI
Suppression of innate immunity by an ADP-ribosyltransferase type III effector$355,714
R01 · FY2011 · AI · contact PI
OXIDATIVE STRESS RESPONSES IN PATHOGENIC PSEUDOMONAS SPECIES$67,218
P20 · FY2011 · RR · contact PI
Suppression of innate immunity by an ADP-ribosyltransferase type III effector$359,475
R01 · FY2010 · AI · contact PI
OXIDATIVE STRESS RESPONSES IN PATHOGENIC PSEUDOMONAS SPECIES$70,832
P20 · FY2010 · RR · contact PI
Suppression of innate immunity by an ADP-ribosyltransferase type III effector$363,270
R01 · FY2009 · AI · contact PI
Suppression of innate immunity by an ADP-ribosyltransferase type III effector$363,430
R01 · FY2008 · AI · contact PI
Suppression of innate immunity by ADP ribosyltransferase type III effectors$360,106
R56 · FY2006 · AI · contact PI